Blood disorders can disrupt the blood’s necessary functions, such as fighting infection, supplying oxygen to vital organs, and clotting.

Blood disorders can be cancerous or not cancerous. Through clinical research, we’re studying investigational medicines to see whether they may treat blood cancers, like lymphoma and leukemia, as well as blood disorders not associated with cancer.

MOCT-Web-TA-Image-Hematologic_card size

Blood cancer trials

Through our clinical trials, we're studying ways to treat various blood-related cancers like lymphoma, leukemia, and more.
View blood cancer trials
GettyImages-1160108775-1-1

Blood disorders (not associated with cancer)

Our goal is to understand and ultimately treat blood disorders such as clotting and bleeding disorders.
View blood disorder trials

There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.

You can also call our clinical trial information center at 1-888-577-8839 to learn more.

icon-checkmark

If you’re not sure which area of focus you’re interested in, let our match tool guide you with 
just a few questions.

Match me

Status

Recruiting

Trial Name

A Study of Nemtabrutinib Versus Comparator in First Line Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

Age

18+

Number of Locations

21

Sexes Studied

Male/Female

Nearest Location

10.17 miles

Condition

Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia

Trial ID

MK-1026-011

Clinicaltrials.gov

NCT06136559

""
See Trial Details

Status

Recruiting

Trial Name

A Study of Zilovertamab Vedotin in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Age

18+

Number of Locations

11

Sexes Studied

Male/Female

Nearest Location

11.52 miles

Condition

DLBCL, Diffuse Large B-Cell Lymphoma

Trial ID

MK-2140-003

Clinicaltrials.gov

NCT05139017

Waveline Oncology Clinical Trials
See Trial Details

Status

Recruiting

Trial Name

Efficacy and Safety of Nemtabrutinib in Participants With Hematologic Malignancies

Age

18+

Number of Locations

15

Sexes Studied

Male/Female

Nearest Location

18.99 miles

Condition

Waldenstroms Macroglobulinaemia, Chronic Lymphocytic Leukaemia, Hematologic Malignancies, Non-Hodgkins Lymphoma

Trial ID

MK-1026-003

Clinicaltrials.gov

NCT04728893

""
See Trial Details

Status

Recruiting

Trial Name

A Study of Zilovertamab Vedotin as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies

Age

18+

Number of Locations

25

Sexes Studied

Male/Female

Nearest Location

19.34 miles

Condition

Richter Transformation Lymphoma, Chronic Lymphocytic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma

Trial ID

MK-2140-006

Clinicaltrials.gov

NCT05458297

Waveline Oncology Clinical Trials
See Trial Details

Status

Recruiting

Trial Name

A Study of Pembrolizumab in Pediatric Participants With an Advanced Solid Tumor or Lymphoma

Age

0 - 17

Number of Locations

5

Sexes Studied

Male/Female

Nearest Location

21.41 miles

Condition

Solid Tumor, Classical Hodgkin Lymphoma, Lymphoma, Melanoma, Microsatellite-instability-high Solid Tumor

Trial ID

MK-3475-051

Clinicaltrials.gov

NCT02332668

Keynote Oncology Clinical Trials
See Trial Details

Resources for patients

For help understanding clinical trial listings and for other resources, visit our Patient Resources section.
Browse resources

About clinical trials

Learn what clinical trials are, how they work, and if you may be eligible to participate.
Learn more about clinical trials